Trevena
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Trevena and buy or sell other stocks, ETFs, and their options commission-free!About TRVN
Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045.
CEOCarrie L. Bourdow
CEOCarrie L. Bourdow
Employees43
Employees43
HeadquartersChesterbrook, Pennsylvania
HeadquartersChesterbrook, Pennsylvania
Founded2007
Founded2007
Employees43
Employees43
TRVN Key Statistics
Market cap101.00M
Market cap101.00M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume881.54K
Average volume881.54K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.97
52 Week high$0.97
52 Week low$0.1195
52 Week low$0.1195
Stock Snapshot
With a market cap of 101M, Trevena(TRVN) trades at $0.58.
On 2025-12-31, Trevena(TRVN) stock opened at —, reached a high of —, and a low of —.
The Trevena(TRVN)'s current trading volume is 0, compared to an average daily volume of 881.54K.
During the past year, Trevena(TRVN) stock moved between $0.12 at its lowest and $0.97 at its peak.
During the past year, Trevena(TRVN) stock moved between $0.12 at its lowest and $0.97 at its peak.
People also own
Based on the portfolios of people who own TRVN. This list is generated using Robinhood data, and it’s not a recommendation.